Ergocalciferol with calcium lactate and calcium phosphate
Brand names: Calcium with Vitamin D
This is a combination preparation of ergocalciferol (vitamin D2) with calcium lactate and calcium phosphate, used to treat or prevent combined calcium and vitamin D deficiency.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Ergocalciferol is converted to active vitamin D metabolites that enhance intestinal absorption of calcium and phosphate, while the calcium salts directly supply elemental calcium for bone mineralisation.
Prescribing in practice
- Avoid in hypercalcaemia, hypercalciuria and conditions with vitamin D oversensitivity, as the combined calcium and vitamin D load can precipitate or worsen hypercalcaemia.
- Calcium salts reduce absorption of oral tetracyclines, levothyroxine, bisphosphonates and some quinolones, so separate administration times.
- Use with caution in renal impairment, sarcoidosis and a history of calcium-containing renal stones.
Monitoring
Monitor serum and urinary calcium periodically, especially in renal impairment or where high doses are used long term.
Counselling the patient
- Take other medicines such as thyroid tablets or certain antibiotics at a different time from this supplement.
- Report nausea, constipation, excessive thirst or passing large amounts of urine, which can indicate high calcium.
- Do not take additional calcium or vitamin D products without advice.
Evidence & guidelines
Combined calcium and vitamin D supplementation is supported by NICE guidance for correcting deficiency and as an adjunct in osteoporosis management.
Reference: NICE NG121; Royal Osteoporosis Society; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Parkland Formula for Burns Fluid Resuscitation · Burns
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Corrected Calcium · Electrolytes
- Calcium-Phosphate Product · Electrolytes
- Corrected Calcium (for Albumin) · Electrolytes
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023